EU Commission Probes Sanofi's Seasonal Flu Vaccine Market Dominance
The EU Commission has launched an investigation into Sanofi's activities in the seasonal flu vaccine market. The inspections, which began at Sanofi's German and French premises, are ongoing but the specific start date remains unclear. The probe centres on suspected anti-competitive practices and alleged abuse of a dominant market position in the stock market today.
Sanofi has acknowledged the inspections and is fully cooperating with the EU Commission. The European Commission's inspections are an initial investigatory step, focusing on potential anti-competitive practices in the seasonal flu vaccine market. The probe alleges that Sanofi may have abused its dominant market position in this sector of the stock market.
The EU Commission's investigation into Sanofi's activities in the seasonal flu vaccine market is ongoing. Sanofi has confirmed the inspections and is working with the EU Commission. The outcome of the investigation remains to be seen.
Read also:
- chaos unveiled on Clowning Street: week 63's antics from 'Two-Tier Keir' and his chaotic Labour Circus
- Budget discrepancy jeopardizes highway projects' financial support
- Racing ahead in Renewable Energy Dominance: Changzhou, Jiangsu Pushes for Worldwide Renewable Energy Ascendancy
- Renault Group to Discuss Decarbonization and Circular Economy Strategies at ChangeNow 2023 Event
